Your browser doesn't support javascript.
loading
The Efficacy Comparison of Endoscopic Bariatric Therapies: 6-Month Versus 12-Month Intragastric Balloon Versus Endoscopic Sleeve Gastroplasty.
Kozlowska-Petriczko, K; Pawlak, K M; Wojciechowska, K; Reiter, A; Blaszczyk, L; Szelemej, J; Petriczko, J; Wiechowska-Kozlowska, A.
Afiliación
  • Kozlowska-Petriczko K; Translational Medicine Group, Pomeranian Medical University, Szczecin, Poland. kkpetriczko@gmail.com.
  • Pawlak KM; Endoscopy Unit, Department of Gastroenterology, Hospital of the Ministry of Interior and Administration, Szczecin, Poland.
  • Wojciechowska K; Department of Internal Medicine and Gastroenterology, Pomeranian Medical University, Szczecin, Poland.
  • Reiter A; Endoscopy Unit, Regional Health Center, Lubin, Poland.
  • Blaszczyk L; Endoscopy Unit, Sonomed Medical Centre, Szczecin, Poland.
  • Szelemej J; Endoscopy Unit, Regional Health Center, Lubin, Poland.
  • Petriczko J; Department of Plastic, Endocrine and General Surgery, Pomeranian Medical University, Szczecin, Poland.
  • Wiechowska-Kozlowska A; Endoscopy Unit, Department of Gastroenterology, Hospital of the Ministry of Interior and Administration, Szczecin, Poland.
Obes Surg ; 33(2): 498-505, 2023 02.
Article en En | MEDLINE | ID: mdl-36525237
INTRODUCTION: Intragastric balloon (IGB) insertion and endoscopic sleeve gastroplasty (ESG) are known to be effective and safe in achieving weight loss. The aim of this study was to compare the effects of a 6-month IGB therapy, a 12-month IGB therapy, and ESG. METHODS: We retrospectively analyzed the weight loss at IGB (Orbera) removal after 6 months (124 patients), at IGB (Orbera365) removal after 12 months (61 patients) and at 6 and 12 months after ESG (42 and 34 patients, respectively). Postprocedural care, including medication and diet, was the same for all procedures. RESULTS: Mean TBWL in patients undergoing IGB placement for 6 and 12 months and ESG after 6 and 12 months were 15.2, 15.8, 26.5, and 28.7 kg, respectively. There was no significant difference in the mean %TBWL in patients undergoing IGB placement for 6 or for 12 months (15.3% vs. 14.7%, P = 0.7). ESG patients showed a significantly higher mean %TBWL than IGB patients after 6 months (15.3 vs. 19.8, P = 0.005) and 12 months (14.7 vs. 22.5, P < 0.001). CONCLUSION: All three studied methods were effective for achieving weight loss. However, there was no significant difference between 6-month and 12-month IGB therapies outcomes. ESG appeared to be a more effective obesity treatment modality than IGB.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Mórbida / Gastroplastia / Balón Gástrico / Bariatria Límite: Humans Idioma: En Revista: Obes Surg Asunto de la revista: METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Obesidad Mórbida / Gastroplastia / Balón Gástrico / Bariatria Límite: Humans Idioma: En Revista: Obes Surg Asunto de la revista: METABOLISMO Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Estados Unidos